Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 385 to 386 of 386 entries
Sorted by: Best Match Show Resources per page
Competing Risks of Cancer and Non-Cancer Mortality When Accompanied by Lifestyle-Related Factors-A Prospective Cohort Study in Middle-Aged and Older Adults.

Frontiers in oncology

Macek P, Biskup M, Terek-Derszniak M, Manczuk M, Krol H, Naszydlowska E, Smok-Kalwat J, Gozdz S, Zak M.
PMID: 33330023
Front Oncol. 2020 Nov 30;10:545078. doi: 10.3389/fonc.2020.545078. eCollection 2020.

BACKGROUND: The study aimed to identify the association between the lifestyle-related factors and the cancer-specific, or non-cancer-specific mortality, when accompanied by a competing risk. Two statistical methods were applied, i.e., cause-specific hazard (CSH), and sub-distribution hazard ratio (SHR). Their...

Cite
Macek P, Biskup M, Terek-Derszniak M, et al. Competing Risks of Cancer and Non-Cancer Mortality When Accompanied by Lifestyle-Related Factors-A Prospective Cohort Study in Middle-Aged and Older Adults. Front Oncol. 2020;10:545078doi: 10.3389/fonc.2020.545078.
Macek, P., Biskup, M., Terek-Derszniak, M., Manczuk, M., Krol, H., Naszydlowska, E., Smok-Kalwat, J., Gozdz, S., & Zak, M. (2020). Competing Risks of Cancer and Non-Cancer Mortality When Accompanied by Lifestyle-Related Factors-A Prospective Cohort Study in Middle-Aged and Older Adults. Frontiers in oncology, 10545078. https://doi.org/10.3389/fonc.2020.545078
Macek, Pawel, et al. "Competing Risks of Cancer and Non-Cancer Mortality When Accompanied by Lifestyle-Related Factors-A Prospective Cohort Study in Middle-Aged and Older Adults." Frontiers in oncology vol. 10 (2020): 545078. doi: https://doi.org/10.3389/fonc.2020.545078
Macek P, Biskup M, Terek-Derszniak M, Manczuk M, Krol H, Naszydlowska E, Smok-Kalwat J, Gozdz S, Zak M. Competing Risks of Cancer and Non-Cancer Mortality When Accompanied by Lifestyle-Related Factors-A Prospective Cohort Study in Middle-Aged and Older Adults. Front Oncol. 2020 Nov 30;10:545078. doi: 10.3389/fonc.2020.545078. eCollection 2020. PMID: 33330023; PMCID: PMC7734021.
Copy Download .nbib Format: NLM
After 20 Years of Advocacy, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Finally Become Law.

Transplantation

Levan ML, Reich DJ, Segev DLL.
PMID: 34342961
Transplantation. 2022 Jan 01;106(1):9-11. doi: 10.1097/TP.0000000000003899.

No abstract available.

Cite
Levan ML, Reich DJ, Segev DLL. After 20 Years of Advocacy, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Finally Become Law. Transplantation. 2022;106(1):9-11doi: 10.1097/TP.0000000000003899.
Levan, M. L., Reich, D. J., & Segev, D. L. L. (2022). After 20 Years of Advocacy, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Finally Become Law. Transplantation, 106(1), 9-11. https://doi.org/10.1097/TP.0000000000003899
Levan, Macey L, et al. "After 20 Years of Advocacy, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Finally Become Law." Transplantation vol. 106,1 (2022): 9-11. doi: https://doi.org/10.1097/TP.0000000000003899
Levan ML, Reich DJ, Segev DLL. After 20 Years of Advocacy, Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Finally Become Law. Transplantation. 2022 Jan 01;106(1):9-11. doi: 10.1097/TP.0000000000003899. PMID: 34342961; PMCID: PMC8678179.
Copy Download .nbib Format: NLM
Showing 385 to 386 of 386 entries